Conditions: Nasopharyngeal Cancinoma (NPC)
Interventions: Drug: PD-1 inhibitor; Drug: Capecitabine
Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fujian Cancer Hospital; Sun Yat-Sen University Cancer Center; Hunan Cancer Hospital; Xiangya Hospital of Central South University; Peking University Cancer Hospital & Institute; Cancer Hospital of Guizhou Province; The First Affiliated Hospital of Air Force Medicial University; Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Recruiting Conditions: Nasopharyngeal Cancinoma (NPC)
Interventions: Drug: PD-1 inhibitor; Drug: Capecitabine
Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fujian Cancer Hospital; Sun Yat-Sen University Cancer Center; Hunan Cancer Hospital; Xiangya Hospital of Central South University; Peking University Cancer Hospital & Institute; Cancer Hospital of Guizhou Province; The First Affiliated Hospital of Air Force Medicial University; Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Recruiting
